Cargando…
IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis
BACKGROUND: The main therapy for rectal cancer patients is neoadjuvant therapy (NT) followed by surgery. Immune biomarkers are emerging as potential predictors of the response to NT. We performed a meta‐analysis to estimate their predictive significance. METHODS: A systematic literature search of Pu...
Autores principales: | Stepanyan, Astghik, Fassan, Matteo, Spolverato, Gaya, Castagliuolo, Ignazio, Scarpa, Melania, Scarpa, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523971/ https://www.ncbi.nlm.nih.gov/pubmed/37537787 http://dx.doi.org/10.1002/cam4.6423 |
Ejemplares similares
-
Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response
por: Kotsafti, Andromachi, et al.
Publicado: (2020) -
IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients – a cohort study
por: Spolverato, Gaya, et al.
Publicado: (2023) -
Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
por: Kotsafti, Andromachi, et al.
Publicado: (2020) -
CD80 expression is upregulated by TP53 activation in human cancer epithelial cells
por: Scarpa, Melania, et al.
Publicado: (2021) -
PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
por: Fassan, Matteo, et al.
Publicado: (2019)